BAG, URINAL

The contract is for the procurement of 3 packages of 20 absorbent urinal bags, each package designed to replace traditional plastic urinals by suppressing cleaning efforts while still allowing for accurate measurement of diuresis and analysis, and eliminating odors. The item, identified by NSN 6530016086210 and part number 939Y37373, is classified as a Class I medical device regulated by the FDA, requiring compliance with registration, listing, labeling, and current Good Manufacturing Practices, even though a 510(k) premarket notification is not mandated. Delivery is required within five days to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor bears all costs and risks until delivery. The packaging must comply with commercial standards as outlined in MIL-STD-2073-1E, with palletization following DLA’s RP001 requirements and labeling adhering strictly to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical acquisitions. Marking must include machine-readable barcodes and comply with all federal and defense regulations, including cybersecurity safeguards such as NIST SP 800-171 and DFARS 252.204-7012 for safeguarding covered defense information. The contract prohibits the use of hazardous materials like hexavalent chromium and covered telecommunications equipment from restricted vendors. Payment must be processed via Wide Area WorkFlow, with invoicing done as an Invoice and Receiving Report upon delivery. The solicitation requires offerors to have an active Unique Entity ID and CAGE code registered in SAM and to affirmatively represent their small business status and socioeconomic certifications. All proposals must be submitted electronically via the DLA Internet Bid Board System by July 28, 2026, with no options or extensions specified, and the award is expected to be based on a fixed-price structure under FAR Clause 52.216-1 Alternate I.